Retrieve available abstracts of 6 articles: HTML format
Single Articles
February 2025
CHEN JG, Kensler TW, Zhu J, Zhu YR, et al Profound primary prevention of liver cancer following a natural experiment in
China: A 50-year perspective and public health implications.
Int J Cancer. 2025;156:756-763. PubMedAbstract available
October 2024
LIU J, Zhang X, Lin J, Dai C, et al HBcrAg is associated with prognosis of hepatitis B virus-related hepatocellular
carcinoma in patients after hepatectomy undergoing antiviral therapy.
Int J Cancer. 2024 Oct 25. doi: 10.1002/ijc.35224. PubMedAbstract available
April 2024
KARTSONAKI C, Yao P, Butt J, Jeske R, et al Infectious pathogens and risk of esophageal, gastric and duodenal cancers and
ulcers in China: A case-cohort study.
Int J Cancer. 2024;154:1423-1432. PubMedAbstract available
January 2024
ZHAO G, Shi X, Zhang L, Liang H, et al Comment on "Diabetic MAFLD is associated with increased risk of hepatocellular
carcinoma and mortality in chronic viral hepatitis patients".
Int J Cancer. 2024 Jan 11. doi: 10.1002/ijc.34796. PubMed
KIM MN, Zhang X, Ahn SH Reply to: Comments on "Diabetic MAFLD is associated with increased risk of
hepatocellular carcinoma and mortality in chronic viral hepatitis patients".
Int J Cancer. 2024 Jan 11. doi: 10.1002/ijc.34797. PubMed
August 2023
HA Y, Lim J, Chon YE, Kim MN, et al Five-year on-treatment variables-based PPACS model predicts subsequent
hepatocellular carcinoma in entecavir/tenofovir-treated patients.
Int J Cancer. 2023 Aug 24. doi: 10.1002/ijc.34704. PubMedAbstract available